What are the Real Lessons from Vioxx???

This publication has 13 references indexed in Scilit:

• Agencies “failed miserably” over COX-2 inhibitor
  BMJ, 2005
• Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
  The Lancet, 2004
• Assessing the Impact of Drug Safety Signals from the WHO Database Presented in ???SIGNAL???
  Drug Safety, 2003
• COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
  The Lancet, 2002
• Labelling and ???Dear Doctor??? Letters
  Drug Safety, 2002
• Risk management of marketed drugs: FDA and the interface with the practice of medicine
  Pharmacoepidemiology and Drug Safety, 2001
• Identification of Sulfonamide-like Adverse Drug Reactions to Celecoxib in the World Health Organization Database
  Current Medical Research and Opinion, 2001
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Impact and Credibility of the Who Adverse Reaction Signals
  Drug Information Journal, 1996